Acute Pancreatitis in Chronic Dialysis Patients

Mary Barbara, Adrianne Tsen, Laura Rosenkranz

Research output: Contribution to journalReview article

Abstract

The annual incidence of acute pancreatitis (AP) ranges from 4.9 to 73.4 cases per 100,000 worldwide. Patients with end-stage renal disease on dialysis have an increased risk for developing AP compared with patients without renal disease. In addition to the general population risk factors, there are factors related to renal insufficiency and dialysis process that might predispose to AP in this population. Clinical features and diagnosis are the same as those in patients without renal failure; however, amylase and lipase levels should be interpreted cautiously as they might be falsely elevated in renal failure. In this article, we will describe the risk factors that are exclusive to this population. In addition, we will also focus on the laboratory indices and clinical features that are unique to this population with patients with end-stage renal disease.

LanguageEnglish (US)
Pages946-951
Number of pages6
JournalPancreas
Volume47
Issue number8
DOIs
StatePublished - Sep 1 2018
Externally publishedYes

Fingerprint

Chronic Pancreatitis
Dialysis
Pancreatitis
Renal Insufficiency
Population
Chronic Kidney Failure
Amylases
Lipase
Renal Dialysis
Kidney
Incidence

Keywords

  • acute pancreatitis
  • chronic kidney disease
  • hemodialysis
  • peritoneal dialysis
  • renal failure

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Acute Pancreatitis in Chronic Dialysis Patients. / Barbara, Mary; Tsen, Adrianne; Rosenkranz, Laura.

In: Pancreas, Vol. 47, No. 8, 01.09.2018, p. 946-951.

Research output: Contribution to journalReview article

Barbara, Mary ; Tsen, Adrianne ; Rosenkranz, Laura. / Acute Pancreatitis in Chronic Dialysis Patients. In: Pancreas. 2018 ; Vol. 47, No. 8. pp. 946-951.
@article{a5dd2dfcebfb49a2aef7dbb9a91afc44,
title = "Acute Pancreatitis in Chronic Dialysis Patients",
abstract = "The annual incidence of acute pancreatitis (AP) ranges from 4.9 to 73.4 cases per 100,000 worldwide. Patients with end-stage renal disease on dialysis have an increased risk for developing AP compared with patients without renal disease. In addition to the general population risk factors, there are factors related to renal insufficiency and dialysis process that might predispose to AP in this population. Clinical features and diagnosis are the same as those in patients without renal failure; however, amylase and lipase levels should be interpreted cautiously as they might be falsely elevated in renal failure. In this article, we will describe the risk factors that are exclusive to this population. In addition, we will also focus on the laboratory indices and clinical features that are unique to this population with patients with end-stage renal disease.",
keywords = "acute pancreatitis, chronic kidney disease, hemodialysis, peritoneal dialysis, renal failure",
author = "Mary Barbara and Adrianne Tsen and Laura Rosenkranz",
year = "2018",
month = "9",
day = "1",
doi = "10.1097/MPA.0000000000001119",
language = "English (US)",
volume = "47",
pages = "946--951",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Acute Pancreatitis in Chronic Dialysis Patients

AU - Barbara, Mary

AU - Tsen, Adrianne

AU - Rosenkranz, Laura

PY - 2018/9/1

Y1 - 2018/9/1

N2 - The annual incidence of acute pancreatitis (AP) ranges from 4.9 to 73.4 cases per 100,000 worldwide. Patients with end-stage renal disease on dialysis have an increased risk for developing AP compared with patients without renal disease. In addition to the general population risk factors, there are factors related to renal insufficiency and dialysis process that might predispose to AP in this population. Clinical features and diagnosis are the same as those in patients without renal failure; however, amylase and lipase levels should be interpreted cautiously as they might be falsely elevated in renal failure. In this article, we will describe the risk factors that are exclusive to this population. In addition, we will also focus on the laboratory indices and clinical features that are unique to this population with patients with end-stage renal disease.

AB - The annual incidence of acute pancreatitis (AP) ranges from 4.9 to 73.4 cases per 100,000 worldwide. Patients with end-stage renal disease on dialysis have an increased risk for developing AP compared with patients without renal disease. In addition to the general population risk factors, there are factors related to renal insufficiency and dialysis process that might predispose to AP in this population. Clinical features and diagnosis are the same as those in patients without renal failure; however, amylase and lipase levels should be interpreted cautiously as they might be falsely elevated in renal failure. In this article, we will describe the risk factors that are exclusive to this population. In addition, we will also focus on the laboratory indices and clinical features that are unique to this population with patients with end-stage renal disease.

KW - acute pancreatitis

KW - chronic kidney disease

KW - hemodialysis

KW - peritoneal dialysis

KW - renal failure

UR - http://www.scopus.com/inward/record.url?scp=85051943653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051943653&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001119

DO - 10.1097/MPA.0000000000001119

M3 - Review article

VL - 47

SP - 946

EP - 951

JO - Pancreas

T2 - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 8

ER -